Showing 1 - 20 results of 20 for search 'Daniel Heudobler', query time: 0.05s
Refine Results
-
1
-
2
Editorial: Integrating transcriptional modulation in systemic tumor therapy by Daniel Heudobler, Daniel Heudobler, Florian Lüke, Lina Ghibelli, Albrecht Reichle
Published 2024-02-01
Article -
3
-
4
Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity by Dennis Christoph Harrer, Florian Lüke, Florian Lüke, Tobias Pukrop, Tobias Pukrop, Lina Ghibelli, Christopher Gerner, Albrecht Reichle, Daniel Heudobler, Daniel Heudobler
Published 2024-01-01
Article -
5
Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature by Dennis Christoph Harrer, Florian Lüke, Ingo Einspieler, Karin Menhart, Dirk Hellwig, Kirsten Utpatel, Wolfgang Herr, Albrecht Reichle, Daniel Heudobler, Daniel Heudobler
Published 2022-05-01
Article -
6
-
7
All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma by Matthias A. Fante, Dennis C. Harrer, Barbara Zartner, Florian Lüke, Florian Lüke, Stephanie Mayer, Karin Menhart, Albrecht Reichle, Wolfgang Herr, Martin Vogelhuber, Daniel Heudobler, Daniel Heudobler
Published 2023-05-01
Article -
8
All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma by Matthias A. Fante, Mona Felsenstein, Stephanie Mayer, Michael Gerken, Michael Gerken, Monika Klinkhammer-Schalke, Monika Klinkhammer-Schalke, Wolfgang Herr, Martin Vogelhuber, Albrecht Reichle, Daniel Heudobler, Daniel Heudobler
Published 2022-05-01
Article -
9
-
10
-
11
Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy by Florian Lüke, Dennis C. Harrer, Joachim Hahn, Matthias Grube, Tobias Pukrop, Wolfgang Herr, Albrecht Reichle, Daniel Heudobler
Published 2021-06-01
Article -
12
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients w... by Daniel Heudobler, Daniel Heudobler, Christian Schulz, Jürgen R. Fischer, Peter Staib, Thomas Wehler, Thomas Wehler, Thomas Südhoff, Thomas Schichtl, Jochen Wilke, Joachim Hahn, Florian Lüke, Martin Vogelhuber, Sebastian Klobuch, Tobias Pukrop, Tobias Pukrop, Wolfgang Herr, Swantje Held, Kristine Beckers, Gauthier Bouche, Albrecht Reichle
Published 2021-03-01
Article -
13
Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis) by Albrecht Reichle, Daniel Heudobler, Christopher Gerner, Pan Pantziarka, Pan Pantziarka, Eugenio Martinelli, Ernst Holler, Francesca Corsi, Francesca Corsi, Lina Ghibelli
Published 2020-09-01
Article -
14
Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue—Going Beyond Apoptosis Induction by Daniel Heudobler, Florian Lüke, Martin Vogelhuber, Sebastian Klobuch, Tobias Pukrop, Wolfgang Herr, Christopher Gerner, Pan Pantziarka, Pan Pantziarka, Lina Ghibelli, Albrecht Reichle
Published 2019-12-01
Article -
15
Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease by Florian Lüke, Dennis C. Harrer, Karin Menhart, Daniel Wolff, Ernst Holler, Dirk Hellwig, Wolfgang Herr, Matthias Grube, Martin Vogelhuber, Albrecht Reichle, Daniel Heudobler
Published 2021-06-01
Article -
16
Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis by Daniel Heudobler, Michael Rechenmacher, Florian Lüke, Martin Vogelhuber, Sebastian Klobuch, Simone Thomas, Tobias Pukrop, Christina Hackl, Wolfgang Herr, Lina Ghibelli, Christopher Gerner, Albrecht Reichle
Published 2018-11-01
Article -
17
958 BNT211: a phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors by John Haanen, Alexander Desuki, Andreas Mackensen, Ugur Sahin, Christian Koenecke, Winfried Alsdorf, Eva Wagner-Drouet, Daniel Heudobler, Peter Borchmann, Erol Wiegert, Catrine Schulz, Benjamin Rengstl, Liane Preussner, Oezlem Tuereci
Published 2021-11-01Article -
18
Breakouts—A Radiological Sign of Poor Prognosis in Patients With Brain Metastases by Raquel Blazquez, Martin Andreas Proescholdt, Marlene Klauser, Karl-Michael Schebesch, Christian Doenitz, Daniel Heudobler, Lena Stange, Markus J. Riemenschneider, Elisabeth Bumes, Katharina Rosengarth, Andreas Schicho, Nils-Ole Schmidt, Alexander Brawanski, Tobias Pukrop, Christina Wendl
Published 2022-04-01
Article -
19
Coronavirus disease 2019 induces multi‐lineage, morphologic changes in peripheral blood cells by Florian Lüke, Evelyn Orsó, Jana Kirsten, Hendrik Poeck, Matthias Grube, Daniel Wolff, Ralph Burkhardt, Dirk Lunz, Matthias Lubnow, Barbara Schmidt, Florian Hitzenbichler, Frank Hanses, Bernd Salzberger, Matthias Evert, Wolfgang Herr, Christoph Brochhausen, Tobias Pukrop, Albrecht Reichle, Daniel Heudobler
Published 2020-07-01
Article -
20
Identification of Disparities in Personalized Cancer Care—A Joint Approach of the German WERA Consortium by Florian Lüke, Florian Haller, Kirsten Utpatel, Markus Krebs, Norbert Meidenbauer, Alexander Scheiter, Silvia Spoerl, Daniel Heudobler, Daniela Sparrer, Ulrich Kaiser, Felix Keil, Christoph Schubart, Lars Tögel, Sabine Einhell, Wolfgang Dietmaier, Ralf Huss, Sebastian Dintner, Sebastian Sommer, Frank Jordan, Maria-Elisabeth Goebeler, Michaela Metz, Diana Haake, Mithun Scheytt, Elena Gerhard-Hartmann, Katja Maurus, Stephanie Brändlein, Andreas Rosenwald, Arndt Hartmann, Bruno Märkl, Hermann Einsele, Andreas Mackensen, Wolfgang Herr, Volker Kunzmann, Ralf Bargou, Matthias W. Beckmann, Tobias Pukrop, Martin Trepel, Matthias Evert, Rainer Claus, Alexander Kerscher
Published 2022-10-01
Article